In addition, it has been found that a subset of human GBM cases showed high expression of CD44 in brain tumour stem-like cells (BTSC), and that the growth of these tumours might depend on CD44v6/AKT signaling pathway (Jijiwa et al., 2011). This evidence concerns the gene CD44 and brain neoplasm.